American International Group, Inc. Theravance Biopharma, Inc. Transaction History

American International Group, Inc.

  • $8.5 Billion
  • Q3 2024

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024
SELL
$8.22 - $11.59 $13,710 - $19,332
-1,668 Reduced 6.51%
23,942 $214,000
Q4 2023

Feb 13, 2024
SELL
$8.58 - $11.4 $21,707 - $28,842
-2,530 Reduced 8.99%
25,610 $287,000
Q3 2023

Nov 13, 2023
SELL
$8.38 - $10.44 $12,972 - $16,161
-1,548 Reduced 5.21%
28,140 $242,000
Q2 2023

Aug 04, 2023
SELL
$10.16 - $11.92 $18,572 - $21,789
-1,828 Reduced 5.8%
29,688 $307,000
Q1 2023

May 12, 2023
BUY
$9.87 - $11.44 $6,178 - $7,161
626 Added 2.03%
31,516 $341,000
Q4 2022

Feb 10, 2023
BUY
$9.65 - $11.34 $3,107 - $3,651
322 Added 1.05%
30,890 $346,000
Q3 2022

Nov 14, 2022
BUY
$8.39 - $10.22 $3,624 - $4,415
432 Added 1.43%
30,568 $310,000
Q2 2022

Aug 12, 2022
BUY
$8.41 - $10.34 $2,909 - $3,577
346 Added 1.16%
30,136 $273,000
Q1 2022

May 13, 2022
SELL
$8.33 - $12.96 $17,468 - $27,177
-2,097 Reduced 6.58%
29,790 $285,000
Q4 2021

Feb 11, 2022
SELL
$7.42 - $11.05 $7,071 - $10,530
-953 Reduced 2.9%
31,887 $352,000
Q3 2021

Nov 12, 2021
BUY
$6.77 - $14.41 $20,086 - $42,754
2,967 Added 9.93%
32,840 $243,000
Q2 2021

Aug 13, 2021
BUY
$14.52 - $22.46 $38,986 - $60,305
2,685 Added 9.88%
29,873 $434,000
Q1 2021

May 07, 2021
BUY
$16.57 - $21.08 $1,193 - $1,517
72 Added 0.27%
27,188 $555,000
Q4 2020

Feb 12, 2021
SELL
$14.89 - $20.16 $5,792 - $7,842
-389 Reduced 1.41%
27,116 $482,000
Q3 2020

Nov 04, 2020
SELL
$14.79 - $22.49 $9,258 - $14,078
-626 Reduced 2.23%
27,505 $407,000
Q2 2020

Aug 12, 2020
SELL
$20.64 - $30.69 $18,637 - $27,713
-903 Reduced 3.11%
28,131 $590,000
Q1 2020

May 04, 2020
BUY
$17.84 - $31.21 $18,482 - $32,333
1,036 Added 3.7%
29,034 $671,000
Q4 2019

Feb 05, 2020
BUY
$16.12 - $25.89 $1,225 - $1,967
76 Added 0.27%
27,998 $725,000
Q3 2019

Nov 08, 2019
SELL
$16.51 - $23.78 $3,235 - $4,660
-196 Reduced 0.7%
27,922 $544,000
Q2 2019

Aug 23, 2019
BUY
$15.6 - $25.15 $438,640 - $707,167
28,118 New
28,118 $459,000
Q2 2019

Aug 13, 2019
SELL
$15.6 - $25.15 $430,606 - $694,215
-27,603 Closed
0 $0
Q1 2019

May 06, 2019
SELL
$22.57 - $28.15 $20,200 - $25,194
-895 Reduced 3.14%
27,603 $626,000
Q4 2018

Feb 13, 2019
BUY
$22.52 - $35.07 $1,553 - $2,419
69 Added 0.24%
28,498 $729,000
Q3 2018

Nov 09, 2018
BUY
$22.83 - $32.67 $11,711 - $16,759
513 Added 1.84%
28,429 $929,000
Q2 2018

Aug 08, 2018
BUY
$22.06 - $25.52 $18,684 - $21,615
847 Added 3.13%
27,916 $633,000
Q1 2018

May 07, 2018
SELL
$23.37 - $29.71 $24,889 - $31,641
-1,065 Reduced 3.79%
27,069 $656,000
Q4 2017

Feb 09, 2018
BUY
$25.82 - $35.66 $3,459 - $4,778
134 Added 0.48%
28,134 $785,000
Q3 2017

Nov 09, 2017
BUY
$23.88 - $34.96 $668,640 - $978,880
28,000
28,000 $959,000

Others Institutions Holding TBPH

# of Institutions
122
Shares Held
47.3M
Call Options Held
200
Put Options Held
12.8K
View Full List

About Theravance Biopharma, Inc.

TBPH Quotes by TradingView
  • Ticker TBPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 66,782,400
  • Market Cap $666M
  • Description
  • Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...
More about TBPH
Track This Portfolio

Track American International Group, Inc. Portfolio

Follow American International Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email